Evidence map›Paper›PMID 32925079›Full record

ReviewJournal of Huntington's disease2020

The Neurodevelopmental Hypothesis of Huntington's Disease.

Ellen van der Plas, Jordan L Schultz, Peg C Nopoulos

Open access · greenAbstract readReview
In one paragraph

Review in Journal of Huntington's disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Systemic Symptoms in Huntington's Disease: A Comprehensive Review.Movement disorders clinical practice · 2024
    Pooled it
  2. Article
  3. Observational
  4. Exploring huntington's disease from a neurodevelopmental perspective.International journal of biological sciences · 2026
    Review
  5. Review
  6. Review
  7. Movement disorders: a brief overview from an evolutionary perspective.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ellen van der PlasUniversity of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA, USA.
Jordan L SchultzUniversity of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA, USA.
Peg C NopoulosUniversity of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA, USA.
University of Iowa · US

Funding

Longitudinal Assessment of Brain Structure and Function in Juvenile Onset Huntington's DiseaseU01NS055903 · NINDS · UNIVERSITY OF IOWA · PI NOPOULOS, PEGGY C · 2019 to 2025
$17.4M
Growth and Development of the Striatum in Huntington's DiseaseR01NS055903 · NINDS · UNIVERSITY OF IOWA · PI PEGGY C NOPOULOS · 2009 to 2026
$5.0M
NINDS NIH HHS R01 NS055903NINDS NIH HHS U01 NS055903
6 · The paper itself

Abstract

The current dogma of HD pathoetiology posits it is a degenerative disease affecting primarily the striatum, caused by a gain of function (toxicity) of the mutant mHTT that kills neurons. However, a growing body of evidence supports an alternative theory in which loss of function may also influence the pathology.This theory is predicated on the notion that HTT is known to be a vital gene for brain development. mHTT is expressed throughout life and could conceivably have deleterious effects on brain development. The end event in the disease is, of course, neurodegeneration; however the process by which that occurs may be rooted in the pathophysiology of aberrant development.To date, there have been multiple studies evaluating molecular and cellular mechanisms of abnormal development in HD, as well as studies investigating abnormal brain development in HD animal models. However, direct study of how mHTT could affect neurodevelopment in humans has not been approached until recent years. The current review will focus on the most recent findings of a unique study of children at-risk for HD, the Kids-HD study. This study evaluates brain structure and function in children ages 6-18 years old who are at risk for HD (have a parent or grand-parent with HD).

Indexed as

BrainGenetic Predisposition to DiseaseHuntington DiseaseIntelligenceNeurodevelopmental DisordersAdolescentChildHumansHuntingtin ProteinHTT protein, humanHuntingtin ProteinBrain developmentchildren at risk for HDHuntington’s diseaseMRI

Identifiers

PMID32925079
PMCPMC7683043
OpenAlexW3086400053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.